Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (191-200 of 544) with videos related to

Pageof 55
Sort By:
Breast Cancer Research and Treatment|December 28, 2014
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implicationsKatarzyna J Jerzak, Jessica Cockburn, Gregory R Pond, et al.
Cancers|March 13, 2024
Impact of Pre-Diagnostic Risk Factors on Short- and Long-Term Ovarian Cancer Survival Trajectories: A Longitudinal Observational StudyShana J Kim, Shelley S Tworoger, Barry P Rosen, et al.
BMC Medical Genetics|May 1, 2015
Germline TP53 mutational spectrum in French Canadians with breast cancerSuzanna L Arcand, Mohammed R Akbari, Anne-Marie Mes-Masson, et al.
Gynecologic Oncology|May 11, 2010
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutationDanielle Vicus, Amy Finch, Barry Rosen, et al.
Breast Cancer Research and Treatment|January 14, 2012
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screeningKelly A Metcalfe, Nida Mian, Melissa Enmore, et al.
Cancer Biology & Therapy|December 19, 2006
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progressionRobert K Nam, Linda Sugar, Zhenghui Wang, et al.
Clinical Epidemiology|October 6, 2018
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the USLeah J McGrath, Robert A Overman, Diane Reams, et al.
BMC Cancer|March 27, 2014
Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'Joanne Kotsopoulos, Kelly Metcalfe, Jill Alston, et al.
Cancers|June 22, 2023
Vitamin D and Calcium Supplement Use and High-Risk Breast Cancer: A Case-Control Study among <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersEmma Guyonnet, Shana J Kim, Katherine Pullella, et al.
Springerplus|October 4, 2014
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsyRaj Satkunasivam, William Zhang, John Trachtenberg, et al.
Pageof 55

Showing results (191-200 of 544) with videos related to

Sort By:
Pageof 55
Breast Cancer Research and Treatment|December 28, 2014
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implicationsKatarzyna J Jerzak, Jessica Cockburn, Gregory R Pond, et al.
Cancers|March 13, 2024
Impact of Pre-Diagnostic Risk Factors on Short- and Long-Term Ovarian Cancer Survival Trajectories: A Longitudinal Observational StudyShana J Kim, Shelley S Tworoger, Barry P Rosen, et al.
BMC Medical Genetics|May 1, 2015
Germline TP53 mutational spectrum in French Canadians with breast cancerSuzanna L Arcand, Mohammed R Akbari, Anne-Marie Mes-Masson, et al.
Gynecologic Oncology|May 11, 2010
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutationDanielle Vicus, Amy Finch, Barry Rosen, et al.
Breast Cancer Research and Treatment|January 14, 2012
Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screeningKelly A Metcalfe, Nida Mian, Melissa Enmore, et al.
Cancer Biology & Therapy|December 19, 2006
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progressionRobert K Nam, Linda Sugar, Zhenghui Wang, et al.
Clinical Epidemiology|October 6, 2018
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the USLeah J McGrath, Robert A Overman, Diane Reams, et al.
BMC Cancer|March 27, 2014
Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'Joanne Kotsopoulos, Kelly Metcalfe, Jill Alston, et al.
Cancers|June 22, 2023
Vitamin D and Calcium Supplement Use and High-Risk Breast Cancer: A Case-Control Study among <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersEmma Guyonnet, Shana J Kim, Katherine Pullella, et al.
Springerplus|October 4, 2014
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsyRaj Satkunasivam, William Zhang, John Trachtenberg, et al.
Pageof 55